Surface plasmon resonance for the label-free detection of Alzheimer’s β-amyloid peptide aggregation
暂无分享,去创建一个
[1] M. Gobbi,et al. Use of surface plasmon resonance to study the elongation kinetics and the binding properties of the highly amyloidogenic Aβ(1-42) peptide, synthesized by depsi-peptide technique. , 2011, Biosensors & bioelectronics.
[2] Min-Gon Kim,et al. Surface plasmon resonance analysis of Alzheimer's beta-amyloid aggregation on a solid surface: from monomers to fully-grown fibrils. , 2008, Analytical chemistry.
[3] Y. Ihara,et al. γ-Secretase: Successive Tripeptide and Tetrapeptide Release from the Transmembrane Domain of β-Carboxyl Terminal Fragment , 2009, The Journal of Neuroscience.
[4] Alexander K. Buell,et al. Biosensor‐based label‐free assays of amyloid growth , 2009, FEBS letters.
[5] Giuseppe Spoto,et al. Surface plasmon resonance imaging for nucleic acid detection , 2012, Analytical and Bioanalytical Chemistry.
[6] T. Wengenack,et al. Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid β peptide capturing- and plaque binding-monoclonal antibodies , 2009, Alzheimer's & Dementia.
[7] L. K. Baker,et al. Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability* , 2002, The Journal of Biological Chemistry.
[8] P. Katsamba,et al. Analyzing a kinetic titration series using affinity biosensors. , 2006, Analytical biochemistry.
[9] K. Blennow,et al. Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease , 2013, PloS one.
[10] P. Lansbury,et al. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.
[11] Zhiyuan Hu,et al. Label-free detection of Alzheimer's disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide. , 2015, Chemical communications.
[12] H. Kung,et al. Congo red and thioflavin‐T analogs detect Aβ oligomers , 2007 .
[13] M. Groenning,et al. Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils—current status , 2010, Journal of chemical biology.
[14] Roland Winter,et al. Solvation-assisted pressure tuning of insulin fibrillation: from novel aggregation pathways to biotechnological applications. , 2006, Journal of molecular biology.
[15] Kenjiro Ono,et al. Kinetic modeling and determination of reaction constants of Alzheimer's beta-amyloid fibril extension and dissociation using surface plasmon resonance. , 2002, Biochemistry.
[16] C. Ionescu-Zanetti,et al. Surface-catalyzed Amyloid Fibril Formation* , 2002, The Journal of Biological Chemistry.
[17] Ronald Wetzel,et al. Kinetic analysis of beta-amyloid fibril elongation. , 2004, Analytical biochemistry.
[18] M. Fändrich,et al. The aggregation kinetics of Alzheimer's β‐amyloid peptide is controlled by stochastic nucleation , 2005, Protein science : a publication of the Protein Society.
[19] A. Bonvin,et al. The α‐to‐β Conformational Transition of Alzheimer's Aβ‐(1–42) Peptide in Aqueous Media is Reversible: A Step by Step Conformational Analysis Suggests the Location of β Conformation Seeding , 2006 .
[20] A. Bush,et al. Enzyme solid-state support assays: a surface plasmon resonance and mass spectrometry coupled study of immobilized insulin degrading enzyme , 2009, European Biophysics Journal.
[21] K. Matsuzaki,et al. “Click Peptide“: pH‐Triggered in Situ Production and Aggregation of Monomer Aβ1–42 , 2009, Chembiochem : a European journal of chemical biology.
[22] Richard W. Clarke,et al. Direct characterization of amyloidogenic oligomers by single-molecule fluorescence , 2008, Proceedings of the National Academy of Sciences.
[23] M. Perugini,et al. Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways. , 2008, Journal of molecular biology.
[24] Shinichiro Nakamura,et al. Two Distinct Amyloid β-Protein (Aβ) Assembly Pathways Leading to Oligomers and Fibrils Identified by Combined Fluorescence Correlation Spectroscopy, Morphology, and Toxicity Analyses* , 2011, The Journal of Biological Chemistry.
[25] B. Graves,et al. Equilibrium analysis of high affinity interactions using BIACORE. , 1998, Analytical biochemistry.
[26] Ville Leinonen,et al. Immunohistochemical visualization of amyloid-beta protein precursor and amyloid-beta in extra- and intracellular compartments in the human brain. , 2010, Journal of Alzheimer's disease : JAD.
[27] I. Lindberg,et al. The Neuroendocrine Protein 7B2 Suppresses the Aggregation of Neurodegenerative Disease-related Proteins , 2012, The Journal of Biological Chemistry.
[28] M. Mattson,et al. Deglycosylated anti‐amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration , 2007, The European journal of neuroscience.
[29] Ruth Nussinov,et al. Aβ(1–42) Fibril Structure Illuminates Self-recognition and Replication of Amyloid in Alzheimer’s , 2015, Nature Structural &Molecular Biology.
[30] John M Finke,et al. Kinetic analysis of IgG antibodies to beta-amyloid oligomers with surface plasmon resonance. , 2015, Analytical biochemistry.
[31] D. Selkoe,et al. Preventing Alzheimer’s Disease , 2012, Science.
[32] K. Lam,et al. Congo red and thioflavin-T analogs detect Abeta oligomers. , 2008, Journal of Neurochemistry.
[33] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[34] M. Leone,et al. Thioflavin T Promotes Aβ(1-40) Amyloid Fibrils Formation. , 2012, The journal of physical chemistry letters.
[35] P. Aisen,et al. Development of Abeta terminal end-specific antibodies and sensitive ELISA for Abeta variant. , 2004, Biochemical and biophysical research communications.
[36] R. Finke,et al. Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature. , 2009, Biochimica et biophysica acta.
[37] Nicholas W. Smith,et al. Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (aβ) self-assembly. , 2012, ACS chemical neuroscience.
[38] A. Sheikh,et al. Lysophosphatidylcholine modulates fibril formation of amyloid beta peptide , 2011, The FEBS journal.
[39] Judianne Davis,et al. Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils , 2010, Nature Structural &Molecular Biology.